Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection

Lung Cancer

Volumn 65, Issue 1, 2009, Pages 41-48

  Yao, Huixin ^a,b   Zhang, Zhiqiang ^a,c   Xiao, Zhiqiang ^a   Chen, Yongheng ^e   li, Cui ^a   Zhang, Pengfei ^a   Li, Meixiang ^a   Liu, Yingfu ^a   Guan, Yongjun ^d   Yu, Yanhui ^d   Chen, Zhuchu ^a,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

^c XINJIANG MEDICAL UNIVERSITY   (China)

^d Central South University   (China)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Laser capture microdissection; Lung squamous carcinoma; Lymph node metastasis; Quantitative proteomics; Two dimensional difference gel electrophoresis

Indexed keywords

CYTOKERATIN 19; HEAT SHOCK PROTEIN 27; LIPOCORTIN 2; PROTEIN 14 3 3;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LASERS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRODISSECTION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 67349199945     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.10.024     Document Type: Article

References (40)

1. Hoffman P.C., Mauer A.M., and Vokes E.E. Lung cancer. Lancet 355 (2000) 479-485
2. Lopez A.D. Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ 317 (1998) 1399-1400
3. Parkin D.M., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J Clin 49 (1999) 33-64, 31
4. Strauss G.M., Kwiatkowski D.J., Harpole D.H., Lynch T.J., Skarin A.T., and Sugarbaker D.J. Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J Clin Oncol 13 (1995) 1265-1279
5. Salgia R., Harpole D., Herndon II J.E., Pisick E., Elias A., and Skarin A.T. Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. Anticancer Res 21 (2001) 1241-1246
6. Reymond M.A., and Schlegel W. Proteomics in cancer. Adv Clin Chem 44 (2007) 103-142
7. Murray G.I. An overview of laser microdissection technologies. Acta Histochem 109 (2007) 171-176
8. Van den Bergh G., and Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr Opin Biotechnol 15 (2004) 38-43
9. Alfonso P., Nunez A., Madoz-Gurpide J., Lombardia L., Sanchez L., and Casal J.I. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 5 (2005) 2602-2611
10. Bredemeyer A.J., Lewis R.M., Malone J.P., Davis A.E., Gross J., Townsend R.R., et al. A proteomic approach for the discovery of protease substrates. Proc Natl Acad Sci USA 101 (2004) 11785-11790
11. Zhou G., Li H., DeCamp D., Chen S., Shu H., Gong Y., et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 1 (2002) 117-124
12. Greengauz-Roberts O., Stoppler H., Nomura S., Yamaguchi H., Goldenring J.R., Podolsky R.H., et al. Saturation labeling with cysteine-reactive cyanine fluorescent dyes provides increased sensitivity for protein expression profiling of laser-microdissected clinical specimens. Proteomics 5 (2005) 1746-1757
13. Lee J.R., Baxter T.M., Yamaguchi H., Wang T.C., Goldenring J.R., and Anderson M.G. Differential protein analysis of spasomolytic polypeptide expressing metaplasia using laser capture microdissection and two-dimensional difference gel electrophoresis. Appl Immunohistochem Mol Morphol 11 (2003) 188-193
14. Sitek B., Potthoff S., Schulenborg T., Stegbauer J., Vinke T., Rump L.C., et al. Novel approaches to analyse glomerular proteins from smallest scale murine and human samples using DIGE saturation labelling. Proteomics 6 (2006) 4337-4345
15. Yang Y.X., Xiao Z.Q., Chen Z.C., Zhang G.Y., Yi H., Zhang P.F., et al. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics 6 (2006) 2009-2021
16. Pei H., Zhu H., Zeng S., Li Y., Yang H., Shen L., et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 6 (2007) 2495-2501
17. Ebert M., Yokoyama M., Kobrin M.S., Friess H., Lopez M.E., Buchler M.W., et al. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 54 (1994) 3959-3962
18. Goto H., Yano S., Zhang H., Matsumori Y., Ogawa H., Blakey D.C., et al. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. Cancer Res 62 (2002) 3711-3715
19. Cho W.C., and Cheng C.H. Oncoproteomics: current trends and future perspectives. Expert Rev Proteomics 4 (2007) 401-410
20. Taylor B.S., Varambally S., and Chinnaiyan A.M. A systems approach to model metastatic progression. Cancer Res 66 (2006) 5537-5539
21. Zhang H., Wang Y., Chen Y., Sun S., Li N., Lv D., et al. Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain. Lung Cancer 57 (2007) 37-45
22. Tian T., Hao J., Xu A., Luo C., Liu C., Huang L., et al. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 98 (2007) 1265-1274
23. Jiang D., Ying W., Lu Y., Wan J., Zhai Y., Liu W., et al. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3 (2003) 724-737
24. Youn B.S., Kim D.S., Kim J.W., Kim Y.T., Kang S., and Cho N.H. NM23 as a prognostic biomarker in ovarian serous carcinoma. Mod Pathol (2008)
25. Liu L., Zhao L., Zhang Y., Zhang Q., and Ding Y. Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer. Cell Biol Int 31 (2007) 805-814
26. Hayes M.J., and Moss S.E. Annexins and disease. Biochem Biophys Res Commun 322 (2004) 1166-1170
27. Gerke V., and Moss S.E. Annexins: from structure to function. Physiol Rev 82 (2002) 331-371
28. Brichory F.M., Misek D.E., Yim A.M., Krause M.C., Giordano T.J., Beer D.G., et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 98 (2001) 9824-9829
29. Hajjar K.A., Jacovina A.T., and Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269 (1994) 21191-21197
30. Tanaka T., Akatsuka S., Ozeki M., Shirase T., Hiai H., and Toyokuni S. Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 23 (2004) 3980-3989
31. Semov A., Moreno M.J., Onichtchenko A., Abulrob A., Ball M., Ekiel I., et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 280 (2005) 20833-20841
32. Gillette J.M., Chan D.C., and Nielsen-Preiss S.M. Annexin 2 expression is reduced in human osteosarcoma metastases. J Cell Biochem 92 (2004) 820-832
33. Elpek G.O., Karaveli S., Simsek T., Keles N., and Aksoy N.H. Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS 111 (2003) 523-530
34. Lemieux P., Oesterreich S., Lawrence J.A., Steeg P.S., Hilsenbeck S.G., Harvey J.M., et al. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis 17 (1997) 113-123
35. Xu L., Chen S., and Bergan R.C. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 25 (2006) 2987-2998
36. Prasad G.L., Valverius E.M., McDuffie E., and Cooper H.L. Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ 3 (1992) 507-513
37. Osada H., Tatematsu Y., Yatabe Y., Nakagawa T., Konishi H., Harano T., et al. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene 21 (2002) 2418-2424
38. Cheng A.L., Huang W.G., Chen Z.C., Peng F., Zhang P.F., Li M.Y., et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res 14 (2008) 435-445
39. Moll R., Franke W.W., Schiller D.L., Geiger B., and Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 (1982) 11-24
40. Chen T.F., Jiang G.L., Fu X.L., Wang L.J., Qian H., Wu K.L., et al. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor. Lung Cancer 56 (2007) 105-114